|I am a member of the Advisory Board of the
American Antitrust Institute, an independent Washington-based
non-profit education, research, and advocacy organization. Our
mission is to increase the role of competition, assure that
competition works in the interests of consumers, and challenge
abuses of concentrated economic power in the American and world
economy. We have a centrist legal-economic ideology and promote the
vigorous use of antitrust as a vital component of national and
international competition policy.
In December 2010, I filed an amicus
brief on behalf of eight Scholars of Biotechnology Patent Law
in Association for Molecular Pathology v. U.S. Patent &
Trademark Office (Myriad Genetics), Fed. Cir., No. 2010-1406,
arguing that claims 5 and 6 of U.S. Patent No. 5,747,282 should be
held invalid under the printed matter doctrine.